Rifampin Injection Shortage Update: Current Availability and Manufacturer Information

What’s in Shortage

Rifampin Injection (Brand Name: RIFAMPIN) is currently listed in a shortage status by the FDA. This medication is classified as an anti-infective and is provided in an injection dosage form (600 mg).

Which Manufacturers Are Affected

The following manufacturers are currently listed in the FDA database regarding the supply of Rifampin Injection:

• Mylan Institutional, a Viatris Company

  • Status: Available
  • Presentation: Rifampin, Injection, 600 mg/10 mL (NDC 67457-445-60)
  • Contact: 800-796-9526

• Fresenius Kabi USA, LLC

  • Status: Available
  • Presentation: Rifampin, Injection, 600 mg (NDC 63323-351-20)
  • Note: The manufacturer suggests checking with wholesalers for current inventory.
  • Contact: 888-386-1300

Why There’s a Shortage

The FDA source data does not provide a specific reason for the current shortage status of Rifampin Injection.

What Patients Should Do

If you or a loved one are prescribed Rifampin Injection, please consider the following practical steps:

• Consult Your Healthcare Provider: Always discuss your treatment plan and any concerns regarding medication availability with your doctor.
• Speak with a Pharmacist: Clinical or hospital pharmacists can provide the most up-to-date information regarding their specific facility’s inventory.
• Contact Manufacturers: You may use the contact numbers provided above to inquire about supply distribution and availability in your area.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or pharmacist regarding medical treatments and alternatives.

Source

Information provided by the FDA Drug Shortage Database.

• Initial Posting Date: 02/17/2021
• Last Updated: 02/05/2026